08|24|2021
Taper Tantrum 2.0? | August 20, 2021
Taper Tantrum 2.0 looks inevitable, but will it be as bad as last time? Monday The S&P 500 dug itself quite the hole on Monday morning. It spent the...
08|17|2021
Calm Before The Storm? | August 13, 2021
AUTHOR: Jason J. Roque, CFP®, APMA®, AWMA® TITLE: Investment Adviser Rep – CCO TAGS: S&P 500, This was a quiet week for markets. Is this the calm before the...
08|10|2021
The Pendulum | August 6, 2021
This last week was like a pendulum as the markets swung back and forth. Should this continue? Monday Markets slipped on Monday with the S&P 500 shifting down less...
08|03|2021
Holding the Economy at Bay | July 30, 2021
Markets were little changed last week, but the economic calendar was not light. What’s holding markets at bay? Monday Markets gained on Monday as the week got underway. The...
07|27|2021
Rocky Growth | July 23, 2021
In spite of a rocky start, markets grew nicely this last week. Should we expect more growth to come? Monday Markets dove to open the week. The S&P 500...
07|20|2021
Transitory…| July 16, 2021
Markets shed weight for the first week in four. Is there reason to be concerned or is it transitory… Monday Markets opened the week on a strong note as...
07|13|2021
Run Total | July 9, 2021
There was a little run up on markets from a point total standpoint, but volatility was way up. What does it mean? Monday Happy 4th of July! Tuesday Markets...
07|07|2021
Summer Concern? | July 2, 2021
Markets rose steadily all week. Does this bode well for the summer months, or should we be concerned? Monday Markets were mostly up on Monday. Investor sentiment was buoyed...
06|29|2021
Infrastructure Hopes | June 25, 2021
Markets rose on hopes of an infrastructure compromise. What does it mean for markets and inflation as we look ahead? Monday The new week brought optimism. So much so...
06|22|2021
A Market Pummeling | June 18, 2021
It was a pummeling this last week on the markets. Interest rates fell and markets did as well, will it continue? Monday Novavax announced efficacy data that shows over...